The Centers for Medicare & Medicaid Services (CMS) recently announced it will provide temporary relief from reporting and audit requirements for health care providers and organizations1. While this will allow providers and health plans to focus on providing care to Medicare and Medicaid beneficiaries affected by COVID-19, physicians are advised to postpone routine visits and procedures. Let’s take a closer look at the diabetic patient population and understand how this may affect this group and what the impact may be on care gaps, such as the Diabetes Eye Exam:
- Access to preventive and necessary eye screenings may be limited for diabetic patients at eye care practices
- Diabetic patients may remain undiagnosed for sight-threatening vision complications, such as diabetic retinopathy
- Primary care practices that will be able to perform point-of-care screenings will play a significant role in closing care gaps and improving access to care
Point-of-care testing for diabetic retinopathy has been used for over 20 years to provide high quality, cost-effective, annual diabetic eye exams. Topcon Screen provides an easy solution that can screen a patient in less than 2 minutes as a part of the existing workflow. Topcon Screen is reimbursable with most health plans, meets the HEDIS specifications of a Diabetes Eye Exam and improves access for patients who need these vision-saving eye exams. For more information about Topcon’s retinal cameras, innovative pricing models or to develop a strategy to close the Diabetes Eye Exam care gap, simply send us a message.
Manager, Healthcare Economics and Reimbursement
Peter Boomer works with with Health Plans and Health Systems to improve HEDIS documentation while closing care gaps.
1 Centers for Disease Control and Prevention website, “Trump Administration Makes Sweeping Regulatory Changes to Help U.S. Healthcare System Address COVID-19 Patient Surge”, Accessed April 6, 2020,https://www.cms.gov/newsroom/press-releases/trump-administration-makes-sweeping-regulatory-changes-help-us-healthcare-system-address-covid-19
Disclaimer: Consumer Advertising. No aspect of this advertisement has been approved by the American Medical Association, National Committee for Quality Assurance, or the Centers for Medicare & Medicaid Services.